NCT06484127View on ClinicalTrials.gov

Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Prostate Cancer
Trial Locations (1)

200000

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER